Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
03/23/2000 | WO1999055876A3 Polypeptide with immunogenic properties and with a protein with modified biological functions |
03/23/2000 | WO1999053061A3 Tumor associated nucleic acids and uses therefor |
03/23/2000 | WO1999042588A3 Group b streptococcus antigens |
03/23/2000 | DE19816732A1 Diagnostik und Therapie von Erkrankungen im Zusammenhang mit HHV-8-Infektionen Diagnosis and treatment of diseases associated with HHV-8 infection |
03/23/2000 | CA2706859A1 Mammalian transforming growth factor beta - 9 |
03/23/2000 | CA2343838A1 Atp synthase subunit homolog |
03/23/2000 | CA2343577A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
03/23/2000 | CA2343574A1 Metabotropic gaba receptor complex issued from the central nervous system |
03/23/2000 | CA2343314A1 Polynucleotides and polypeptides basb033 from neisseria meningitidis and their uses |
03/23/2000 | CA2343220A1 Modulation of endothelial cell surface receptor activity in the regulation of angiogenesis |
03/23/2000 | CA2343104A1 Recombinant protein production in urine |
03/23/2000 | CA2343051A1 Streptococcal c beta protein compositions |
03/23/2000 | CA2343006A1 Compositions and methods for the treatment of immune related diseases |
03/23/2000 | CA2343001A1 Stomach polypeptide zsig28 |
03/23/2000 | CA2342958A1 Rna-associated proteins |
03/23/2000 | CA2342738A1 Method for detecting or quantifying basophils and eosinophils |
03/23/2000 | CA2342601A1 Antibodies to c3b(i) for delivery of diagnostic and therapeutic agents to cancer cells |
03/23/2000 | CA2342398A1 Moraxella catarrhalis basb034 polypeptides and uses thereof |
03/23/2000 | CA2342301A1 Human cell junction pdz protein |
03/23/2000 | CA2341767A1 Promotion or inhibition of angiogenesis and cardiovascularization |
03/23/2000 | CA2341315A1 Essential genes from c. albicans and a method for screening antimycotic substances using said genes |
03/23/2000 | CA2341304A1 Compositions and methods for the treatment of tumors |
03/23/2000 | CA2341155A1 Genes encoding for the human and murine death inducer-obliterator-1 |
03/23/2000 | CA2340586A1 T-type calcium channel |
03/22/2000 | EP0986652A1 Reagents and methods useful for detecting diseases of the urinary tract |
03/22/2000 | EP0986646A1 Ubiquitin conjugation proteins |
03/22/2000 | EP0986643A1 Reagents and methods useful for detecting diseases of the breast |
03/22/2000 | EP0986577A2 Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria |
03/22/2000 | EP0986533A1 Identification of a unique receptor specific for a particular retinoid inducing cellular apoptosis |
03/22/2000 | EP0986400A1 Integrin ligand, human mindin |
03/22/2000 | EP0986397A1 Use of leptin antagonists for the treatment of diabet |
03/22/2000 | EP0986396A1 Prion protein modulator factor (ppmf) and prion resistant animals |
03/22/2000 | EP0690874B1 Materials and methods relating to proteins that interact with casein kinase i |
03/22/2000 | CN1248291A Phosphodiesterase 8A |
03/22/2000 | CN1050668C Method for early detection of septicaemia and for treatment-accompanying assessment of course of sepsis, as well as means for carrying out said method |
03/21/2000 | US6040426 Human Th2 specific protein |
03/21/2000 | US6040290 Antitumor agents for inhibiting the growth of adenocarcinoma cells |
03/21/2000 | US6040176 Monoclonal antibody produced by the hybridoma cell line 81k2f (atcc hb 11692) which acts against human intercellular adhesion molecule-r; antiinflammatory/antitumor agents; antimetastasis agents; viricides |
03/21/2000 | US6040173 Nucleic acid encoding a novel mammalian protein associated with uncontrolled cell division |
03/21/2000 | US6040164 Amino acid sequence of enzyme which binds to calmodulin in a calcium-dependent manner and is involved in calcium signalling; for screening agonists and antagonists |
03/21/2000 | US6040163 Amino acid sequence which couples asparagine to transfer rna; for screening bacteriostats and bactericides |
03/21/2000 | US6040162 Amino acid sequence which couples histidine to transfer rna; for screening bacteriostats and bactericides |
03/21/2000 | US6040148 Heat shock protein/antigen having molecular weight of about 86 kilodaltons which induces an antibody to a breakdown product in recovering patients; for immunoassay diagnosis, immunogens and bactericides with reduced side effects |
03/21/2000 | US6040146 Detection of mammary tumor virus-like sequences in human breast cancer |
03/21/2000 | US6040141 Bacterium possessing the markers fpt, ompt-- and dsba--; for expression of fusion protein on surface of bacterium |
03/21/2000 | US6040137 Amino acid sequence of antibody which specifically binds a certain antigen linked to amino acid sequence to which a certain antibody binds; immunoassay diagnostic reagents; therapy by redirecting specificity of patient's antibodies |
03/21/2000 | US6039957 Oligomeric HIV-1 envelope glycoproteins |
03/21/2000 | US6039956 Corticotropin release inhibiting factor and methods of using same for treating behavioral symptoms in an anxiety disorder |
03/21/2000 | US6039948 Amino acid sequences with beta subunit of chorionic gonadotropin endogenous to mammals |
03/21/2000 | US6039684 Non-lethal conditioning methods for the treatment of acquired immunodeficiency syndrome |
03/21/2000 | CA2048655C Discrimination between antibodies against htlv-1, htlv-ii or related retroviruses, new peptides, detection of antibodies and immunoassay kits |
03/21/2000 | CA1340931C Infectious bural disease virus |
03/16/2000 | WO2000014546A1 Tau as a marker for early cns damage |
03/16/2000 | WO2000014545A1 Multihued labels |
03/16/2000 | WO2000014542A2 Diagnostic method for detecting disturbances of the pancreas |
03/16/2000 | WO2000014538A1 Linker-assisted immunoassay for glyphosate |
03/16/2000 | WO2000014536A1 Production of motif-specific and context-independent antibodies using peptide libraries as antigens |
03/16/2000 | WO2000014257A1 Fusion receptors specific for prostate-specific membrane antigen and uses thereof |
03/16/2000 | WO2000014250A1 Tyrosylprotein sulfotransferase polypeptides and polynucleotides |
03/16/2000 | WO2000014240A2 Attenuated salmonella sp12 mutants as antigen carriers |
03/16/2000 | WO2000014235A1 Kunitz domain polypeptide zkun6 |
03/16/2000 | WO2000014231A1 Lim domain protein homolog |
03/16/2000 | WO2000014230A1 Novel molecules of the herpes virus-entry-mediator-related protein family and uses thereof |
03/16/2000 | WO2000014229A1 Novel receptor protein and method for diagnosing inflammatory diseases by using the same |
03/16/2000 | WO2000014228A1 Neutral amino acid transporter and gene thereof |
03/16/2000 | WO2000014227A1 Novel protein and dna thereof |
03/16/2000 | WO2000014222A2 GABAB RECEPTOR SUBTYPES GABAB-R1c AND GABAB-R2 AND HETERODIMERS THEREOF |
03/16/2000 | WO2000014221A1 Glycine transporter |
03/16/2000 | WO2000014220A1 Methods and compositions for modulating the interaction between the apj receptor and the hiv virus |
03/16/2000 | WO2000014214A1 Antibodies for judging possibility of the onset of bovine leukemia |
03/16/2000 | WO2000014212A1 Novel protein kinase molecules and uses therefor |
03/16/2000 | WO2000014200A2 Essential bacterial genes and their use |
03/16/2000 | WO2000014119A2 Bifunctional antibodies and their use in targeting anti-tumour agents |
03/16/2000 | WO2000014118A1 Ozf protein-specific monoclonal antibodies and their diagnostic therapeutic uses |
03/16/2000 | WO2000014107A1 Temperature dependent protein purification |
03/16/2000 | WO2000014106A1 Novel bag proteins and nucleic acid molecules encoding them |
03/16/2000 | WO2000013706A1 Methods for detecting, preventing, and treating renal disorders by modulating, regulating, and inhibiting connective tissue growth factor |
03/16/2000 | WO2000013705A1 Use of tgf-beta inhibitors for treating cerebral disorders |
03/16/2000 | WO2000013699A1 An antigenic peptide encoded by an alternative open reading frame of human macrophage colony-stimulating factor |
03/16/2000 | WO2000013694A1 Gcp |
03/16/2000 | WO2000002897A3 Delta cleavage products and methods based thereon |
03/16/2000 | WO2000002582A3 Treatment of celiac disease with interleukin-15 antagonists |
03/16/2000 | WO1999067391A9 Origin of replication and methods of use |
03/16/2000 | WO1999062939A3 Glycoproteins having lipid mobilising properties and therapeutic applications thereof |
03/16/2000 | WO1999061471A3 Human transmembrane proteins |
03/16/2000 | WO1999060131A3 Hemorrhagic enteritis virus dna sequences, proteins encoded thereby and various uses thereof |
03/16/2000 | WO1999058570A3 Antibodies to the ed-b domain of fibronectin, conjugates containing them and use therefor for diagnosis and therapy of tumors and diseases associated with angiogenesis |
03/16/2000 | WO1999058559B1 Factors affecting tumor necrosis factor receptor releasing enzyme activity |
03/16/2000 | WO1999057151A3 FAP α-SPECIFIC ANTIBODY WITH IMPROVED PRODUCIBILITY |
03/16/2000 | WO1999051723A3 Bacterial transglutaminases |
03/16/2000 | WO1999046385A3 Compositions and methods for the treatment and prevention of metastatic disorders |
03/16/2000 | CA2347054A1 Linker-assisted immunoassay for glyphosate |
03/16/2000 | CA2343351A1 Human transferase proteins |
03/16/2000 | CA2343156A1 Fusion receptors specific for prostate-specific membrane antigen and uses thereof |
03/16/2000 | CA2343136A1 Diagnostic method for detecting disturbances of the pancreas |
03/16/2000 | CA2342963A1 Ozf protein-specific monoclonal antibodies and their diagnostic therapeutic uses |
03/16/2000 | CA2342311A1 Novel protein kinase molecules and uses therefor |
03/16/2000 | CA2342280A1 Methods for detecting, preventing, and treating renal disorders by modulating, regulating, and inhibiting connective tissue growth factor |
03/16/2000 | CA2342208A1 Use of tgf-beta inhibitors for treating cerebral disorders |
03/16/2000 | CA2342027A1 Novel bag proteins and nucleic acid molecules encoding them |